Click here to view this message in a web browser
	Avalere Research on Health Plan - Life Science OBCs: The Rise in Outcomes Based Contracts Wednesday, October 30th, 2019 | 1:00PM - 2:00PM Eastern
	Avalere research findings on payer and life science OBCs, and perceived challenges with OBCs OBC considerations for new/existing products, and therapeutic areas of focus OBC cost savings expectations timelines and potential usage of ancillary services under OBCs Methods to measure value and financial incentives
	New Avalere research finds that 59% of payers have executed an outcomes-based contract. When Avalere first conducted this survey in 2017, 24% of health plans had an OBC in place. Avalere’s survey also found that nearly 60% of health plans with an OBC already in place cited cost savings and clinical improvement as the top advantages of OBCs. Both of these rates have increased since the survey was first conducted in 2017. The capture of real-world information and improved payer–manufacturer relationships were also notable areas of growth.
	Please join us on Wednesday, October 30, 2019, at 1 PM Eastern as Avalere’s Sarah Donovan, John Linnehan and Michael Schneider discuss Avalere OBC research findings, insights and implications. Click here for detailed information or to register or call 209.577.4888.

  

healthexecwire 1101 Standiford Ave., Suite C-3 Modesto, CA 95350 www.healthexecwire.com